LGALS9 and chronic obstructive pulmonary disease: Although the precise mechanisms involved are still unclear, Gal-9-mediated inflammatory responses show beneficial effects in reducing PPE-induced emphysema, suggesting that Gal-9 could be a candidate therapeutic agent for the treatment of pulmonary emphysema and COPD.